Current laboratory diagnosis of coronavirus disease 2019
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Coronavirus disease 2019 (COVID-19) emerged in December 2019 in Wuhan, China; it has since caused a pandemic, with more than 10,000 confirmed cases (> 800,000 tests) in Korea as of May 2020. Real-time reverse transcription polymerase chain reaction (RT-PCR) is currently the most commonly used method for the diagnosis of COVID-19 worldwide. The Korean Society for Laboratory Medicine and Korea Centers for Disease Prevention and Control regularly update the guidelines for COVID-19 diagnosis. Emergency use authorization for some laboratory diagnostic kits has been granted, enabling the timely diagnosis and treatment of COVID-19, and the isolation of infected patients. Due to the collective efforts of the government, medical professionals, local authorities, and the public, Korea’s response to the COVID-19 outbreak has been accepted widely as a model. Here, we summarize the currently available laboratory tests for COVID-19 diagnosis. Although RT-PCR tests are used widely to confirm COVID-19, antibody tests could provide information about immune responses to the virus.
Abstract
Coronavirus disease 2019 (COVID-19) emerged in December 2019 in Wuhan, China; it has since caused a pandemic, with more than 10,000 confirmed cases (> 800,000 tests) in Korea as of May 2020. Real-time reverse transcription polymerase chain reaction (RT-PCR) is currently the most commonly used method for the diagnosis of COVID-19 worldwide. The Korean Society for Laboratory Medicine and Korea Centers for Disease Prevention and Control regularly update the guidelines for COVID-19 diagnosis. Emergency use authorization for some laboratory diagnostic kits has been granted, enabling the timely diagnosis and treatment of COVID-19, and the isolation of infected patients. Due to the collective efforts of the government, medical professionals, local authorities, and the public, Korea’s response to the COVID-19 outbreak has been accepted widely as a model. Here, we summarize the currently available laboratory tests for COVID-19 diagnosis. Although RT-PCR tests are used widely to confirm COVID-19, antibody tests could provide information about immune responses to the virus.
참고문헌 (33)
- Tai W, "Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus:implication for development of RBD protein as a viral attachment inhibitor and vaccine. Version 2", Cell Mol Immunol, 17, pp.613~620 (2020)
- Lippi G, "The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks", Clin Chem Lab Med (2020)[DOI]
- Korea Centers for Disease Control and Prevention, "Guidelines in Response to Coronavirus Disease 2019" (2020), KCDC
- Ki Ho Hong, "Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea", Annals of Laboratory Medicine, 40(5), pp.351~360 (2020), 대한진단검사의학회[DOI]
- "Evaluating testing persons for coronavirus disease 2019 (COVID-19):priorities for COVID-19 testing" (2020)[URL]
- Shaun S Tan, "Practical laboratory considerations amidst the COVID-19 outbreak: early experience from Singapore", Journal of Clinical Pathology, 74(4), pp.257~260 (2021), BMJ[DOI]
- Wang W, "Detection of SARS-CoV-2 in different types of clinical specimens", JAMA, 323, pp.1843~1844 (2020)
- Zitek T, "The Appropriate use of testing for COVID-19", West J Emerg Med, 21, pp.470~472 (2020)
- Giuseppe Lippi, "Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)", Clinical Chemistry and Laboratory Medicine (CCLM), 58(7), pp.1070~1076 (2020), Walter de Gruyter GmbH[DOI]
- 김영진, "COVID-19 Testing in South Korea: Current Status and the Need for Faster Diagnostics", Annals of Laboratory Medicine, 40(5), pp.349~350 (2020), 대한진단검사의학회[DOI]
- Lan L, "Positive RT-PCR test results in patients recovered from COVID-19", JAMA, 323, pp.1502~1503 (2020)
- Li Y, "Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19", J Med Virol, 92, pp.903~908 (2020)
- Andrea Padoan, "Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM", IgG and antibody kinetics, 2020, pp.58(7), 1081~1088[DOI]
- Xiang F, "Antibody detection and dynamic characteristics in patients with COVID-19", Clin Infect Dis (2020)[DOI]
- Guo L, "Profiling early humoral response to diagnose novel coronavirus disease(COVID-19)", Clin Infect Dis (2020)[DOI]
- Quan-Xin Long, "Antibody responses to SARS-CoV-2 in patients with COVID-19", Nature Medicine, 26(6), pp.845~848 (2020), Springer Science and Business Media LLC[DOI]
- Acarturk TO, "Treatment of large ischial ulcers communicating with the hip joint with proximal femoral resection and reconstruction with a combined vastus lateralis, vastus intermedius and rectus femoris musculocutaneous flap", J Plast Reconstr Aesthet Surg, 62, pp.1497~1502 (2009)
- Casadevall A, "The convalescent sera option for containing COVID-19", J Clin Invest, 130, pp.1545~1548 (2020)
- Guangshu Han, "Possibly critical role of wearing masks in general population in controlling COVID‐19", Journal of Medical Virology, 92(10), pp.1779~1781 (2020), Wiley[DOI]
- Maggi F, "Future management of viral diseases : role of new technologies and new approaches in microbial interactions", Clin Microbiol Infect, 25, pp.136~141 (2019)
- Sultana S, "Stability issues and approaches to stabilised nanoparticles based drug delivery system", J Drug Target, 28, pp.468~486 (2020)
- "COVID-19 diagnostics resource centre" (2019)[URL]
- Li Z, "Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis", J Med Virol (2020)[DOI]
- Dohla M, "Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity", Public Health, 182, pp.170~172 (2020)
- Cassaniti I, "Performance of VivaDiag COVID-19 IgM", IgG rapid test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department, 2020, ~
- "Advice on the use of pointof-care immunodiagnostic tests for COVID-19" (2020)[URL]
- Vashist SK, "In vitro diagnostic assays for COVID-19: recent advances and emerging trends", Diagnostics(Basel), 10, pp.202~ (2020)
- Hongzhou Lu, "An evolving approach to the laboratory assessment of COVID‐19", Journal of Medical Virology, 92(10), pp.1812~1817 (2020), Wiley[DOI]
- To KK, "Consistent detection of 2019 novel coronavirus in saliva", Clin Infect Dis (2020)[DOI]
- Mardani R, "Laboratory parameters in detection of COVID-19 patients with positive RT-PCR; a diagnostic accuracy study", Arch Acad Emerg Med, 8, pp.e43~ (2020)
- Gao Y, "Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19", J Med Virol, 92, pp.791~796 (2020)
- John L. Frater, "COVID‐19 and the clinical hematology laboratory", International Journal of Laboratory Hematology, 42(S1), pp.11~18 (2020), Wiley[DOI]
- Han H, "Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China", J Med Virol, 92, pp.819~823 (2020)
